Intellectual Property India Publishes Patent Application for An Engineered Bimodal Sensing Antibody Fragment (cetuximab-Dfd) And Logic Gated Synthetic Notch Car T-Cell Architecture For Overcoming Egfr Drug Resistance In Oncology

MUMBAI, India, Nov. 6 -- Intellectual Property India has published a patent application (202641131275 A) filed by Srm Dental College Ramapuram; and Easwari Engineering College on November 03, 2026, for An Engineered Bimodal Sensing Antibody Fragment (cetuximab-Dfd) And Logic Gated Synthetic Notch Car T-Cell Architecture For Overcoming Egfr Drug Resistance In Oncology.

Inventors include S. N. Sri Varshaa; T. Dinesh Kumar; Nagarathinam Ae; and K. Rajkumar.

The application for the patent was published on November 06, 2026, under issue no. 45/2026.

Abstract: Head and neck squamous cell carcinoma causes nearly a million annual cases, with epidermal growth factor receptor (EGFR)-targeted therapies like cetuximab often failing due to variants l...